Novartis To Step Up Investment In China
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Swiss drug maker Novartis plans to deepen its investment in China this year despite the West's economic downturn, and will expand its research and development center here while launching new drugs in the Chinese market, according to high-level Novartis executives